CLARION

DoD partners with Detect-Ion to develop Point-of-Care Breath Diagnostics for Early Detection of Infected Warfighters

Retrieved on: 
Tuesday, June 6, 2023
Infection, POC, Human, Defense Innovation Unit, Oxygen, United States Department of Defense, COVID-19, Carbon dioxide, Organic compound, Airport, Intelligence, CLARION, Volatile organic compound, VOC, Biomarker, DTRA, Innovation Unit, Science, Argon, Defense Threat Reduction Agency, DARPA, Carbon monoxide, Hospital, Investment, Algorithm, Breath diagnostics, IVD, Nitrogen, PCR, IARPA, Medical imaging

TAMPA, Fla., June 6, 2023 /PRNewswire/ --The recent COVID-19 pandemic has highlighted the need to rapidly detect infected humans to intervene early before severe conditions develop and to mitigate the spread of infections across a larger population. The ideal diagnostics approach should be painless (non-invasive), rapid, cost-effective, accurate, and should be versatile to detect multiple infectious pathogens, in some cases pre-symptomatically (even before the symptoms are visible). This diagnostics capability when applied to United States Department of Defense (DoD) warfighters would ensure mission readiness in austere environments, where providing adequate medical personnel and/or traditional diagnostics labs can be challenging. With this vision, DoD's DIU teamed up with DTRA and has awarded an Other Transaction (OT) contract to Detect-Ion to develop such a Point-of-Care (PoC) Breath Diagnostics.

Key Points: 
  • This diagnostics capability when applied to United States Department of Defense (DoD) warfighters would ensure mission readiness in austere environments, where providing adequate medical personnel and/or traditional diagnostics labs can be challenging.
  • With this vision, DoD's DIU teamed up with DTRA and has awarded an Other Transaction (OT) contract to Detect-Ion to develop such a Point-of-Care (PoC) Breath Diagnostics.
  • CLARION in-vitro diagnostics (IVD) may offer sufficient versatility to potentially screen against multiple infection types in a single breath test.
  • The project is planned over three years and allows DoD to pursue follow-on production if the pilot project succeeds in addressing the program metrics.

SAS Viya now available in the Microsoft Azure Marketplace

Retrieved on: 
Tuesday, September 27, 2022
Efficiency, Product, Achievement, Government, SAS Institute Inc v World Programming Ltd, Organization, Elasticity, S-Bank, Assistant, Information, POWER, COVID, IDC, Science, Analytics, Python, CBI Book of the Year Awards, CLARION, Love, NBG, Senior, Data management, News, Partnership, Language, Microsoft Azure, SAS, Hospital, ISV, TK, Group, Machine learning, Twitter, Partner, Name, Microsoft, Intelligence, Decision-making, Solution, Architecture, Azure, AI, Video game console, Satellite navigation device, Medical device, Viya

CARY, N.C., Sept. 27, 2022 /PRNewswire/ -- SAS Explore -- The SAS® Viya® analytics platform is now available in the Microsoft Azure Marketplace with the click of a button on a pay-as-you-go basis. Full-featured SAS Viya on Microsoft Azure equips customers worldwide with access to essential data exploration, machine learning and model deployment analytics. It's available in many translated languages and includes an extensive in-app learning center to support immediate onboarding and long-term success.

Key Points: 
  • With the availability of SAS Viya on Microsoft Azure, users will have access to the full Viya package that includes SASVisual Analytics, SAS Visual Statistics, SAS Visual Data Mining and Machine Learning, and SAS Model Manager.
  • SAS CEO Jim Goodnight said accessing Viya in the Microsoft Azure Marketplace is a fast and easy way to tap into the power of SAS.
  • They are located all around the world, across all industries, and experience benefits from fellow SAS users and experts within SAS Communities, which will be available directly through SAS Viya on Microsoft Azure.
  • Launching SAS Viya as a "Get It Now" offering in the Microsoft Azure Marketplace represents a continued focus on expanding the SAS/Microsoft strategic partnership.

SAS and bioMérieux join forces to fight antimicrobial resistance

Retrieved on: 
Monday, August 9, 2021
Technology, Software, Infection, CLARION, Data management, Disease, Health, COVID-19, Bacteria, AMR, Center, SAS Institute Inc v World Programming Ltd, HIMSS, Intelligence, Centers for Disease Control and Prevention, Name, EMR, Death, Antibiotic, SAS, Partnership, Anecdote, Public health, Antimicrobial stewardship, Risk, Data collection, Doctor of Pharmacy, Patient, Data visualization, POWER, Fungus, National Health Laboratory Service, Hospital, Pharmaceutical industry, Medical imaging, Satellite navigation device

CARY, N.C., Aug. 9, 2021 /PRNewswire/ -- bioMrieux Inc. , a world leader in in vitro diagnostic solutions for infectious disease, has partnered with global analytics leader SAS to help combat antimicrobial resistance.

Key Points: 
  • CARY, N.C., Aug. 9, 2021 /PRNewswire/ -- bioMrieux Inc. , a world leader in in vitro diagnostic solutions for infectious disease, has partnered with global analytics leader SAS to help combat antimicrobial resistance.
  • The partnership is rooted in the medical community's ongoing fight against antimicrobial resistance and the goal to activate and support continuous improvement within antimicrobial stewardship programs.
  • "CLARION, powered by SAS, revolutionizes antimicrobial stewardship and transforms the antibiogram to be automated and dynamic, providing up-to-date information."
  • SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries.